-
Je něco špatně v tomto záznamu ?
Directly Measured Adherence to Treatment in Chronic Heart Failure: LEVEL-CHF Registry
L. Jelínek, J. Václavík, Z. Ramík, L. Pavlů, K. Benešová, J. Jarkovský, M. Lazárová, H. Janečková, J. Spurná, M. Táborský
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- adherence k farmakoterapii statistika a číselné údaje MeSH
- antagonisté mineralokortikoidních receptorů terapeutické užití MeSH
- antagonisté receptorů pro angiotenzin terapeutické užití MeSH
- beta blokátory terapeutické užití MeSH
- chronická nemoc farmakoterapie MeSH
- inhibitory ACE terapeutické užití MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- senioři MeSH
- srdeční selhání farmakoterapie MeSH
- věkové faktory MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Currently, most available data on the medication adherence of patients with chronic heart failure are based on indirect methods. We examined the level of adherence to medical therapy using a direct method - serum drug level testing. METHODS: We carried out a prospective single-centre registry of patients with chronic heart failure (LEVEL-CHF registry), in whom we analysed serum levels of the medications prescribed for the treatment of heart failure: angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers and mineralocorticoid receptor antagonists. We labelled a patient as non-adherent if at least one serum level of a prescribed drug was unmeasurable (below the detection limit). Patients with all tested drugs identifiable in serum were labelled as adherent. We enrolled 274 patients (208 men and 66 women) mean age 62 years. RESULTS: 82.5% of patients were adherent and 17.5% non-adherent to prescribed medications. 3.6% were completely non-adherent without any detectable drugs in serum. Patients aged <60 years were more likely to be non-adherent than older patients (OR 2.15). No other clinical or laboratory parameters predicted non-adherence. CONCLUSIONS: A significant proportion of outpatients with chronic heart failure were non-adherent to treatment when assessed by a direct method of serum drug level testing. Non-adherence was more likely in younger patients.
Department of Biostatistics and Analysis Masaryk University Brno Czech Republic
Department of Forensic Medicine Olomouc University Hospital Olomouc Czech Republic
Department of Internal Medicine and Cardiology Ostrava University Hospital Ostrava Czech Republic
Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018883
- 003
- CZ-PrNML
- 005
- 20210830100451.0
- 007
- ta
- 008
- 210728s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.amjms.2020.12.004 $2 doi
- 035 __
- $a (PubMed)33781390
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jelínek, Libor $u 1st Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Olomouc University Hospital, Palacky University, Olomouc, Czech Republic. Electronic address: jelineklibor@gmail.com
- 245 10
- $a Directly Measured Adherence to Treatment in Chronic Heart Failure: LEVEL-CHF Registry / $c L. Jelínek, J. Václavík, Z. Ramík, L. Pavlů, K. Benešová, J. Jarkovský, M. Lazárová, H. Janečková, J. Spurná, M. Táborský
- 520 9_
- $a BACKGROUND: Currently, most available data on the medication adherence of patients with chronic heart failure are based on indirect methods. We examined the level of adherence to medical therapy using a direct method - serum drug level testing. METHODS: We carried out a prospective single-centre registry of patients with chronic heart failure (LEVEL-CHF registry), in whom we analysed serum levels of the medications prescribed for the treatment of heart failure: angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers and mineralocorticoid receptor antagonists. We labelled a patient as non-adherent if at least one serum level of a prescribed drug was unmeasurable (below the detection limit). Patients with all tested drugs identifiable in serum were labelled as adherent. We enrolled 274 patients (208 men and 66 women) mean age 62 years. RESULTS: 82.5% of patients were adherent and 17.5% non-adherent to prescribed medications. 3.6% were completely non-adherent without any detectable drugs in serum. Patients aged <60 years were more likely to be non-adherent than older patients (OR 2.15). No other clinical or laboratory parameters predicted non-adherence. CONCLUSIONS: A significant proportion of outpatients with chronic heart failure were non-adherent to treatment when assessed by a direct method of serum drug level testing. Non-adherence was more likely in younger patients.
- 650 _2
- $a beta blokátory $x terapeutické užití $7 D000319
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antagonisté receptorů pro angiotenzin $x terapeutické užití $7 D057911
- 650 _2
- $a inhibitory ACE $x terapeutické užití $7 D000806
- 650 _2
- $a chronická nemoc $x farmakoterapie $7 D002908
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x farmakoterapie $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a adherence k farmakoterapii $x statistika a číselné údaje $7 D055118
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a antagonisté mineralokortikoidních receptorů $x terapeutické užití $7 D000451
- 650 _2
- $a prospektivní studie $7 D011446
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Václavík, Jan $u 1st Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Olomouc University Hospital, Palacky University, Olomouc, Czech Republic; Department of Internal Medicine and Cardiology, Ostrava University Hospital, Ostrava, Czech Republic
- 700 1_
- $a Ramík, Zdeněk $u Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Pavlů, Luděk $u 1st Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Olomouc University Hospital, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Benešová, Klára $u Department of Biostatistics and Analysis, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Jarkovský, Jiří $u Department of Biostatistics and Analysis, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Lazárová, Marie $u 1st Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Olomouc University Hospital, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Janečková, Hana $u Laboratory for Inherited Metabolic Disorders, Olomouc University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Spurná, Jana $u Department of Forensic Medicine, Olomouc University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Táborský, Miloš $u 1st Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Olomouc University Hospital, Palacky University, Olomouc, Czech Republic
- 773 0_
- $w MED00000305 $t The American journal of the medical sciences $x 1538-2990 $g Roč. 361, č. 4 (2021), s. 491-498
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33781390 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100451 $b ABA008
- 999 __
- $a ok $b bmc $g 1689848 $s 1139329
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 361 $c 4 $d 491-498 $e 20201207 $i 1538-2990 $m The American journal of the medical sciences $n Am J Med Sci $x MED00000305
- LZP __
- $a Pubmed-20210728
